Abstract
Voriconazole is widely used for the prevention and treatment of fungal infection in leukemia patients and considered the primary antifungal agent for invasive aspergillosis. We report 60 cases of patients who developed visual disturbance and visual and auditory hallucinations after intravenous voriconazole treatment for invasive pulmonary aspergillosis increased by intravenous Imipenem treatment. The aim of this research is to show how to proceed basing on pharmacokinetics of both voriconazole and imipenem to solve hallucination.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings for Annual Meeting of The Japanese Pharmacological Society
Paper Title
Journal
Date
